Drug intelligence / Profile preview

S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione

Development stage
Unknown
Modality
Small Molecules
01

Overview

S-(N-hydroxy-N‑iodophenylcarbamoyl)glutathione is a synthetic small molecule derivative of glutathione, in which the glutathione moiety is conjugated to an N-hydroxy-N‑iodophenyl carbamoyl group. It has been studied primarily as an experimental inhibitor and ligand for glyoxalase I (also known as lactoylglutathione lyase), an enzyme involved in the detoxification of methylglyoxal via the glyoxalase system. Structural studies have shown that this compound binds to human glyoxalase I, making it useful for probing enzyme mechanism and structure-function relationships[4][7]. There are no approved therapeutic indications or clinical trials reported for this compound; its use is limited to biochemical and structural research.

Other names
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(R)-hydroxy-(N-hydroxy-4-iodoanilino)methyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(R)-hydroxy[hydroxy(4‑iodophenyl)amino]methyl]sulfanyl}ethyl]carbamoyl}butanoic acidL-gamma-glutamyl-S-{(R)-hydroxy[hydroxy(4​-iodophenyl)amino]methyl}-L-cysteinylglycine
02

Targets

GLO1 (Glyoxalase 1)

Beyond the preview

Go deeper on S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call